Cardea Bio (part of Paragraf®)

Semiconductor Manufacturing • San Diego, California, United States • 1-10 Employees

Company overview

Headquarters	8969 Kenamar Dr., Suite 104, San Diego, California 92121, US
Phone number	+441223739782
Website	cardeabio.com
NAICS	333242
SIC	873
Keywords	Biology, BPU, Crispr, Multiomics, Digital Biology, Internet Of Biology, Biosignal Processing Unit
Founded	2019
Employees	1-10
Socials

Key Contact at Cardea Bio (part of Paragraf®)

Thomas Hermann

Senior Director, Manufacturing And Supply Chain

About Cardea Bio (part of Paragraf®)

Cardea Bio is the world’s only mass producer of biocompatible semiconductors, the BPU™ (Biosignal Processing Unit). The BPU is the first and only semiconductor capable of translating real-time streams of multiomics signals into digital information. Through the BPU™ platform, Cardea's long-term vision is to democratize access to the biosignals and insights behind the most advanced technology on our planet: Nature and biology. The Internet of Biology is that way becoming possible. Cardea is headquartered in San Diego and has additional activity in Los Angeles. Cardea is a 100% American developed and built biocompatible semiconductor technology for applications across a variety of sectors including human health, agriculture, molecular diagnostics, biotechnology, environmental monitoring, and animal health. In May 2023, Cardea Bio became part of Paragraf, who has revolutionized graphene electronic device manufacturing with its pioneering scalable approach, making it the world's first company to achieve this feat. The acquisition of Cardea Bio and creation of Paragraf USA will enable Paragraf to offer a new generation of biosensing devices that will deliver the features and result sensitivity of existing lab-based instruments, with the rapid response and simple ease of use required to enable handheld, real-time, in the field use.

Cardea Bio (part of Paragraf®) revenue & valuation

Annual revenue	$6,500,000
Revenue per employee	$929,000
Estimated valuation?This valuation is estimated based on industry average for the Semiconductor Manufacturing industry and current estimated revenues	$20,800,000
Total funding	$1,100,000

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Employees by Department

Cardea Bio (part of Paragraf®) has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Cardea Bio (part of Paragraf®)'s funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-06-03	9	$1,100,000

Funding Insights

$1,100,000

Total funding amount

$1,100,000

Most recent funding amount

Number of funding rounds

Cardea Bio (part of Paragraf®) Tech Stack

Discover the technologies and tools that power Cardea Bio (part of Paragraf®)'s digital infrastructure, from frameworks to analytics platforms.

Ninja Forms

Form builders

Underscore.js

JavaScript libraries

HubSpot CMS Hub

CMS

Slick

JavaScript libraries

Cookie Control

Cookie compliance

DataTables

JavaScript libraries

Animate.css

UI frameworks

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Yoast SEO Premium

SEO

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

Frequently asked questions

Cardea Bio (part of Paragraf®) is located in San Diego, California, US.

You can reach Cardea Bio (part of Paragraf®) at +441223739782.

Cardea Bio (part of Paragraf®) was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Cardea Bio (part of Paragraf®) has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Cardea Bio (part of Paragraf®) has raised a total of $1,100,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Cardea Bio (part of Paragraf®)

Thomas Hermann

Senior Director, Manufacturing And Supply Chain

4.8

40,000 users